Biogen and Bio-Thera Reveal Tocilizumab Progress

Biosimilar Actemra Phase III Results Trigger $30m Payment Under April Deal

 
• By David Wallace
  
Tocilizumab Syringe Hand Glove
Biogen and Bio-Thera have announced Phase III results for their Actemra biosimilar • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products